Date: 2015-04-13
Type of information: Collaboration agreement
Compound:
Company: AstraZeneca (UK) PatientsLikeMe (USA - MA)
Therapeutic area: Autoimmune diseases – Cancer - Oncology - Metabolic diseases - Respiratory diseases
Type agreement: R&D collaboration
Action mechanism:
Disease:
Details: * On April 13, 2015, AstraZeneca and PatientsLikeMe have signed a five-year agreement to provide access to PatientsLikeMe’s global network in support of AstraZeneca’s patient-driven research initiatives. AstraZeneca will use patient-reported data from PatientsLikeMe to shape future medicine development and help improve outcomes across its main therapeutic areas, with an initial focus on respiratory disease, lupus, diabetes and oncology.
Financial terms:
Latest news:
